We found that K 1 /Cl -co-transporter 2 (KCC2) activity, monitored with wide-field fluorescence, was inhibited by intracellular Zn 21 , a major component of neuronal injury. Zn 21 -mediated KCC2 inhibition produced a depolarizing shift of GABA A reversal potentials in rat cortical neurons. Moreover, oxygen-glucose deprivation attenuated KCC2 activity in a Zn 21 -dependent manner. The link between Zn 21 and KCC2 activity provides a previously unknown target for neuroprotection and may be important in activitydependent regulation of inhibitory synaptic transmission.
KCC2 is the major Cl -outward transporter in neurons, creating a Cl -equilibrium potential that is negative to the resting membrane voltage and rendering GABA inhibitory. However, following acute and chronic neuronal injury, KCC2 activity is decreased and GABA becomes excitatory [1] [2] [3] , a process that has been tightly linked to neurodegeneration 4 . Another important contributor to neuronal injury and death is an increase in cytosolic Zn 2+ concentrations ([Zn 2+ ] i ) 5 . Although both a rise in [Zn 2+ ] i and a decrease in KCC2 have been associated with neuronal injury, whether Zn 2+ itself can influence KCC2 activity is unknown.
To test whether [Zn 2+ ] i modulates KCC2 activity, we first monitored KCC2-mediated ion transport in HEK 293T cells expressing the cotransporter 6 . NH 4 + was used as a surrogate ion for K + and changes in intracellular pH were monitored using the fluorescent dye 2¢,7¢-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF; see Supplementary Methods online). KCC2-expressing cells had a NH 4 + -induced acidification rate that was threefold faster than that of cells transfected with empty vector (Fig. 1a,b) . We increased [Zn 2+ ] i by applying the metal in the presence of the Zn 2+ ionophore pyrithione (ZnPyr) for 2 min and observed an immediate decrease of the KCC2-mediated acidification rate, with a 50% inhibition concentration of B50 mM Zn 2+ (Fig. 1a-c with N,N,N¢,N¢-tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN) reversed the effects of ZnPyr (Fig. 1b) . Moreover, TPEN alone increased KCC2 activity (Fig. 1a,b) , indicating that endogenous levels of [Zn 2+ ] i tonically inhibit KCC2.
Next, we directly examined changes in intracellular chloride concentrations ([Cl -] i ) with the Cl --sensitive dye N-(ethoxycarbonylmethyl)6-methoxyquinolinium bromide (MQAE; see Supplementary Methods). Application of 5 mM KCl reversed KCC2 transport, leading to the accumulation of intracellular Cl - (Fig. 1d) . Increasing [Zn 2+ ] i with ZnPyr blocked the Cl -influx (Fig. 1d,e) , whereas TPEN enhanced it (Fig. 1d,e) , similar to the results observed with NH 4 + -induced acidification.
We then tested whether KCC2 inhibition by Zn 2+ is also observed in cortical neurons, which endogenously express the co-transporter. In BCECF-loaded immature neurons (7 d in vitro, DIV) expressing low levels of KCC2, NH 4 + had little effect on intracellular acidification, similar to empty vector-transfected HEK 293T cells (Fig. 1f) . In contrast, in mature neurons (425 DIV), which express high levels of KCC2, NH 4 + -induced acidification was pronounced. Notably, ZnPyr also effectively attenuated KCC2 activity in mature neurons (Fig. 1f) .
Zn 2+ -dependent changes in KCC2 activity should affect the Cl -gradient and thereby the reversal potential of GABA A receptormediated currents (E GABA ). We measured E GABA using the gramicidin perforated-patch technique, which leaves intracellular Cl -undisturbed. A 2-min ZnPyr treatment produced a gradual positive shift in E GABA , as the intracellular Cl -concentration presumably decreased with KCC2 inhibition (Fig. 2a) . E GABA stabilized within 6-8 min of the ZnPyr application to a level that was B20 mV positive to control (Fig. 2b-d) . ZnPyr did not affect E GABA under whole-cell recording conditions with equal extracellular and intracellular chloride (Fig. 2d) . The Zn 2+ -induced shift in E GABA reversed by 30 min after ZnPyr removal (Fig. 2d) , indicating that neurons can tightly regulate [Zn 2+ ] i under non-injurious conditions.
Cerebral ischemia induces acute Zn 2+ dysregulation in neurons 7 . Therefore, we investigated whether KCC2 is inhibited by sustained increases in neuronal [Zn 2+ ] i following oxygen-glucose deprivation (OGD) in mature neurons (Fig. 2e) . Application of an extracellular Zn 2+ chelator did not attenuate the observed [Zn 2+ ] i rise following OGD (Fig. 2e) , strongly suggesting that Zn 2+ is liberated from intracellular binding sites 8 . Notably, NH 4 + -induced acidification rates in ischemic neurons were markedly decreased (Fig. 2f) . Moreover, neurons exposed to TPEN during OGD had normal rates of acidification (Fig. 2f) , indicating that the rise in [Zn 2+ ] i following ischemic insult led to the inhibition of KCC2.
Our results reveal a previously unknown link between [Zn 2+ ] i and KCC2 activity. KCC2 inhibition by Zn 2+ was rapid, suggesting that Zn 2+ may directly interact with intracellular cysteine or histidine residues of KCC2. Alternatively, Zn 2+ could contribute to the known regulation of KCC2 activity by phosphorylation 9 , leading to changes in its expression 9, 10 , or by oligomerization 11 . Zn 2+ , however, did not induce changes in KCC2 transcription, surface expression or oligomeric organization (see Supplementary Figs. 1 and 2 online) , some of which have been observed in other neuronal injury models 2-4,9,10 . Changes in KCC2 activity without changes in expression have also been reported in a deafness model 12 .
The downregulation of KCC2 activity following OGD-induced Zn 2+ rise may account for acute seizure activity following ischemia 13 . A major factor in neuronal injury following OGD is intracellular release of Zn 2+ and it was recently shown that Zn 2+ release is also critical for spreading depression triggered by OGD 14 . Notably, a decrease in GABA inhibition has been proposed to be a mechanism contributing to neuronal death following cerebral ischemia 4 . Our results indicate that Zn 2+ -dependent inhibition of KCC2 may be an important contributor to neuronal injury. We also suggest that influx of synaptically released Zn 2+ or its intracellular release, particularly during periods of intense synaptic activity 15 , may dynamically regulate inhibition by modulating KCC2 activity.
Note: Supplementary information is available on the Nature Neuroscience website. ZnPyr shifted E GABA from -54 to -33 mV. (d) E GABA measured with gramicidin-patch in control neurons (n ¼ 6) at o1 and 6-10 min after ZnPyr (n ¼ 10), and after a 30-min rinse (n ¼ 3). E GABA measured in whole cells (equal extracellular and intracellular chloride conditions) under control conditions (n ¼ 10) and after ZnPyr (n ¼ 5, mean ± s.e.m., *** P o 0.001, ANOVA/Tukey). (e) OGD-induced increase in neuronal [Zn 2+ ] i inhibited KCC2. Neurons were exposed to OGD for 90 min and loaded with the Zn 2+ -sensitive dye FluoZin3. A significant Zn 2+ rise, sensitive to TPEN (20 mM), was monitored at 1 h following OGD. This increase in cytoplasmic Zn 2+ was insensitive to the extracellular Zn 2+ chelator tricine (1 mM), suggesting that the source of the metal was intracellular (n ¼ 7-9, mean ± s.e.m., * P o 0.05, ANOVA/Bonferroni). (f) We monitored neuronal KCC2 activity 1 h after OGD treatment with NH 4 + /BCECF. TPEN treatment during OGD abolished KCC2 inhibition (n ¼ 5-14, mean ± s.e.m., ** P o 0.005, ANOVA/Tukey).
